Found 489 hits.
|
552. |
Mobayed, H.+, Al-Nesf, M. A., Robles-Velasco, K., Cherrez-Ojeda, I., Ensina, L. F., and Maurer, M.: Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report. Front. Allergy 2023: 4; 1228495. IF: 3.30 |
o.552
|
505. |
Bonnekoh, H., Jelden-Thurm, J., Butze, M., Krause, K., Maurer, M., and Kolkhir, P.+: In urticarial vasculitis, long disease duration, high symptom burden, and high need for therapy are linked to low patient-reported quality of life. J. Allergy Clin. Immunol. Pract. 2022: 10; 2734-2741. IF: 9.40 |
o.505
| 111 | Baiardini, I., Braido, F., Bindslev-Jensen, C., Bousquet, P. J., Brzoza, Z., Canonica, G. W., Compalati, E., Fiocchi, A., Fokkens, W., Gerth van Wijk, R. Giménez-Arnau, A., Godse, K., Grattan, C., Grob, J. J., La Grutta, S., Kalogeromitros, D., Kocatürk, E., Lombardi, C., Pinto, A. M., Ridolo, E., Saini, S. S., Sánchez-Borges, M., Senna, G. E., Terreehorst, I., Todo Bom, A., Toubi, E., Bousquet, J., Zuberbier, T., and Maurer, M.+: Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: A GA²LEN taskforce position paper. Allergy 2011: 66; 840-844. IF: 6.27 |
o.111
|
604. |
Cherrez-Ojeda, I.+, Bousquet, J., Giménez-Arnau, A., Godse, K., Krasowska, D., Bartosińska, J., Szczepanik-Kułak, P., Wawrzycki, B., Kolkhir, P., Allenova, A., Allenov, A., Tkachenko, S., Teovska Mitrevska, N., Mijakoski, D., Stoleski, S., Kolacinska-Flont, M., Kuprys-Lipinska, I., Molinska, J., Kasperska-Zając, A., Zajac, M., Zamlynski, M., Mihaltan, F., Ulmeanu, R., Zalewska-Janowska, A., Tomaszewska, K., Al-Ahmad, M., Al-Nesf, M. A., Ibrahim, T., Aqel, S., Pesqué, D., Rodríguez-González, M., Wakida-Kuzunoki, G. H., Ramon, G. D., Ramon, G. N., Neisinger, S., Bonnekoh, H., Rukhadze, M., Khoshkhui, M., Fomina, D., Larenas-Linnemann, D., Košnik, M., Oztas Kara, R., Caballero López, C. G., Liu, Q., Ivancevich, J. C., Ensina, L. F., Rosario, N., Kvedariene, V., Ben-Shoshan, M., Criado, R. F. J., Bauer, A., Cherrez, A., Cherrez, S., Chong-Neto, H., Rojo-Gutierrez, M. I., Rudenko, M., Larco Sousa, J. I., Lesiak, A., Matos, E., Tinoco, I., Crespo Shijin, C., Hinostroza Logroño, R., Sagñay, J. C., Faytong-Haro, M., Robles-Velasco, K., Zuberbier, T., and Maurer, M.+: Usage prevalence of angioedema patient-reported outcome measures: results from the UCARE and ACARE PROMUSE study. J. Allergy Clin. Immunol. Pract. 2024: 12; 2211-2215. IF: TBD (IF 2023: 8.20) |
o.604
|
589. |
Cherrez-Ojeda, I.+, Bousquet, J., Giménez-Arnau, A., Godse, K., Krasowska, D., Bartosińska, J., Szczepanik-Kułak, P., Wawrzycki, B., Kolkhir, P., Allenova, A., Allenov A, Tkachenko S, Teovska Mitrevska N, Mijakoski D, Stoleski S, Kolacinska-Flont, M., Kuprys-Lipinska, I., Molinska, J., Kasperska-Zając, A., Zajac, M., Zamlynski, M., Mihaltan, F., Ulmeanu, R., Zalewska-Janowska, A., Tomaszewska, K., Al-Ahmad, M., Al-Nesf, M. A., Ibrahim, T., Aqel, S., Pesqué, D., Rodríguez-González, M., Wakida-Kuzunoki, G. H., Ramon, G. D., Ramon, G. N., Neisinger, S., Bonnekoh, H., Rukhadze, M., Khoshkhui, M., Fomina, D., Larenas-Linnemann, D., Košnik, M., Oztas Kara, R., Caballero López, C. G., Liu, Q., Ivancevich Juan, C., Ensina, L. F., Rosario, N., Kvedariene, V., Ben-Shoshan, M., Criado, R. F. J., Bauer, A., Cherrez, A., Chong-Neto, H., Rojo-Gutierrez, M. I., Rudenko, M., Larco Sousa, J. I., Lesiak, A., Matos, E., Muñoz, N., Tinoco, I., Moreno, J., Crespo Shijin, C., Hinostroza Logroño, R., Sagñay, J. C., Faytong-Haro, M., Robles-Velasco, K., Zuberbier, T., and Maurer, M.+: Patient-reported outcome measures in atopic dermatitis and chronic urticaria are underused in clinical practice. J. Allergy Clin. Immunol. Pract. 2024: 12; 1575-1583. IF: TBD (IF 2023: 8.20) |
o.589
| 311 | Dressler, C.+, Rosumeck, S., Werner, R. N., Magerl., M., Metz, M., Maurer, M. Nast, A., and Zuberbier, T.: Executive summary of the methods report for ‘The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. The 2017 revision and update’. Allergy 2018: 73; 1145-1146. IF: 6.77 |
| 78. | Maurer, M., Magerl, M., Metz, M., and Zuberbier, T.: Diagnostik und Therapie der chronischen Urtikaria – Was wird von Revision und Aktualisierung der internationalen Leitlinie erwartet? Ein Report der öffentlichen Konsensuskonferenz URTICARIA 2012. Hautarzt 2013: 64; 638-643. IF: 0.54 |
| 77. | Maurer, M., Magerl, M., Metz, M., and Zuberbier, T.: Diagnostik und Therapie der chronischen Urtikaria – was wird von Revision und Aktualisierung der internationalen Leitlinie erwartet? Ein Report der öffentlichen Konsensuskonferenz “URTICARIA 2012”. Allergo J. 2013: 22; 324-329. IF: N/A |
| 104 | Metz, M., Altrichter, S., Ardelean, E., Keßler, B., Krause, K., Magerl, M., Siebenhaar, F., Weller, K., Zuberbier, T., and Maurer, M.+: Anti-immunglobulin E treatment of patients with recalcitrant physical urticaria. Int. Arch. Allergy Immunol. 2011: 154; 177-180. IF: 2.40 |
| 64. | Krause, K., Metz, M., Makris, M., Zuberbier, T., and Maurer, M.: The role of Interleukin-1 in allergy-related disorders. Curr. Opin. Allergy Clin. Immunol. 2012: 12; 477-484. IF: 3.39 |